- Efficacy of the Precise Climate Controller on the reduction of indoor microorganisms
-
Moungthong G, Klamkam P, Mahakit P, Chalermwatanachai T, Thunyaharn S, Monyakul V
- KMID: 2397114
- Asia Pac Allergy.
- 2014 Apr;4(2):113-118.
- doi: 10.5415/apallergy.2014.4.2.113
BACKGROUND: Nowadays, there are many methods to reduce microorganisms in the air, such as dehumidifier, air purifier or humidity and temperature controller. The Precise Climate Controller is an instrument for... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimizing the Dosing Regimens of Tigecycline against VancomycinResistant Enterococci in the Treatment of Intra-abdominal and Skin and Soft Tissue Infections
-
Santimaleeworagun W, Hemapanpairoa J, Changpradub D, Thunyaharn S
- KMID: 2507528
- Infect Chemother.
- 2020 Sep;52(3):345-351.
- doi: 10.3947/ic.2020.52.3.345
Tigecycline was previously considered to have activity against vancomycin-resistant Enterococcus (VRE) isolates, but the optimal dose was not clarified. Thus, this study assessed the in vitro activity of tigecycline against... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimization of Linezolid Dosing Regimens for Treatment of VancomycinResistant Enterococci Infection
-
Santimaleeworagun W, Changpradub D, Hemapanpairoa J, Thunyaharn S
- KMID: 2521227
- Infect Chemother.
- 2021 Sep;53(3):503-511.
- doi: 10.3947/ic.2021.0034
Background: Linezolid, an oxazolidinone antibiotic, is recommended for vancomycinresistant enterococci (VRE). However, 100% free-drug concentration above the minimum inhibitory concentration (fT>MIC) and an area under the curve of free drug... -
- CITED
-
- Close
- SHARE
-
- Close
- Colistin plus Sulbactam or Fosfomycin against Carbapenem-Resistant Acinetobacter baumannii: Improved Efficacy or Decreased Risk of Nephrotoxicity?
-
Saelim W, Changpradub D, Thunyaharn S, Juntanawiwat P, Nulsopapon P, Santimaleeworagun W
- KMID: 2514840
- Infect Chemother.
- 2021 Mar;53(1):128-140.
- doi: 10.3947/ic.2021.0007
Background: Acinetobacter baumannii has been recognized as a cause of nosocomial infection. To date, polymyxins, the last-resort therapeutic agents for carbapenem-resistant A. baumannii (CRAB). Thus, the small number of... -
- CITED
-
- Close
- SHARE
-
- Close
